Latest News

FDA OKs First Darunavir-Based Single-Tablet Treatment Regimen for HIV
Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg) offers a new treatment option to adults living with HIV.
Study finds that specialty drug coverage policies are mostly inconsistent across health plans and many treatments have multiple restrictions to access.
Supplementation of the protein in the nerve cells prevented nerve degeneration, muscle atrophy, and paralysis in an amyloid lateral sclerosis mouse model.
Top news of the day from across the health care landscape.
New research has identified the origins of acute myeloid leukemia, which can be detectable more than 5 years before the disease develops.
Health care providers who offer HIV tests encourage patients to integrate preventive screenings into their health care routines.
Individuals treated for cancer in adolescence or young adulthood may be at higher risk for endocrine diseases, such as thyroid disease, testicular dysfunction, and diabetes.
Most individuals with multiple sclerosis experience pain as a symptom of the disease.


Specialty Pharmacies Honored for Exemplary Patient Support
The Specialty Pharmacy Patient Choice Award was created by Zitter Health Insights and Specialty Pharmacy Times in 2017 to honor specialty pharmacies and their commitment to patients.
While navigating the expanding marketplace, health care innovators must continue to cope with rising costs, barriers to access, and a complicated reimbursement environment.
Caught in the middle of a maelstrom of change currently engulfing the health care industry, specialty pharmacy is emerging as a powerful force that will play a key role in the growing conversations regarding value in health care.
As it is every year, the Asembia Summit was filled with a plethora of information that allowed for networking, business development, and personal development.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Ron Lanton III, Esq., executive director and senior counsel for Frier Levitt Government Affairs, discusses how to boost prescriber uptake of biosimilars.

Luis Torres, MBA, Vice President, Managed Care, BioPlus Specialty Pharmacy, speaks about why data is a crucial component of choosing a specialty pharmacy.

A look at last week's top stories in the world of pharmacy.

Current Issue

2018 Asembia Recap
Volume: 9
Number: 4

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.